Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Successful use of Campath-1H in the treatment of steroid refractory liver GvHD

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1
Figure 2

References

  1. Biggs JC, Szer J, Crilley P et al. Treatment of chronic myeloid leukaemia with allogeneic bone marrow transplantation after preparation with BuCy2. Blood 1992; 80: 1352–1357.

    CAS  PubMed  Google Scholar 

  2. Weisdorf D, Haake R, Blazar B et al. Treatment of moderate/severe acute GvHD after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 1990; 75: 1024–1030.

    CAS  PubMed  Google Scholar 

  3. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute graft versus host disease: secondary treatment. Blood 1991; 77: 1821–1828.

    CAS  PubMed  Google Scholar 

  4. Remberger M, Aschan J, Barkholt L et al. Treatment of acute graft-versus-host disease with antithymocyte globulin. Clin Transplant 2001; 15: 147–153.

    Article  CAS  PubMed  Google Scholar 

  5. Abhyankar S, Godder K, Christiansen N et al. Treatment of resistant acute and chronic graft-versus-host disease with mycophenolate mofetil. Blood 1998; 92 (Suppl.): 340b (abstract 4467).

    Google Scholar 

  6. Farag SS, Bruner R . Monoclonal antibodies for the prevention and treatment of graft-versus-host disease. Semin Oncol 2003; 30: 509–519.

    Article  PubMed  Google Scholar 

  7. Mufti GJ, Fishlock K, Arno M et al. Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with Campath-1H. Blood 2001; 98: 2048 (abstract 1543).

    Google Scholar 

  8. Naparstek E, Or R, Nagler A et al. T-cell depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Br J Haematol 1995; 89: 506–515.

    Article  CAS  PubMed  Google Scholar 

  9. Varadi G, Reuven OR, Slavin S et al. In vivo Campath-1 monoclonal antibodies: a novel mode of therapy for acute graft-versus-host disease. Am J Haematol 1996; 52: 236–237.

    Article  CAS  Google Scholar 

  10. Carella AM, Beltrami G, Scalzulli PR et al. Alemtuzumab can successfully treat steroid-refractory acute graft-versus-host disease (aGvHD). BMT 2004; 33: 131–132.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wandroo, F., Auguston, B., Cook, M. et al. Successful use of Campath-1H in the treatment of steroid refractory liver GvHD. Bone Marrow Transplant 34, 285–287 (2004). https://doi.org/10.1038/sj.bmt.1704573

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704573

This article is cited by

Search

Quick links